117P Safety and effectiveness of cisplatin plus etoposide in hemodialysis patients with lung cancer
Year: 2026
Type: article
Abstract: Data on chemotherapy for hemodialysis (HD) patients are extremely limited. We proposed a full-dose cisplatin plus etoposide (EP) protocol based on plasma concentration monitoring in 5 HD patients; however, evidence from larger cohorts including survival data is lacking.
Source: ESMO Open
Authors: M.M. Saito, G. Saito, S. Yagi, F. Kure, T. Itoh, K. Takagi, H. Ikeda, C. Imai, N. Hattori, T. Suzuki
Institutions: Chiba University, Chiba University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7138037129
FWCI:
Cites:
Cited by:
Related to:
